Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Oral Contraceptives on Women Balance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All women in group (A) had takenthe oral contraceptive pill have done so routinely for the past three months.~* All women in group (B) had a normal menstrual cycle; use any other non-hormonal contraceptive method.~* Their body mass index did not exceed 30 Kg/m2.~* All women had a normal menstrual cycle of 25-32 days for the past 3 months.~* They can stand independently.~Exclusion Criteria:~* Respiratory or heart problems.~* Skeletal deformityorusing assistive devices.~* Visual and vestibular system affection.~* Cognition problems.~* Previous surgeries at their back and/or lower limbs.~* Genital and breast cancer and active liver disease.

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Oral contraceptive pills users (Type: ACTIVE_COMPARATOR): The participants received treatment for 6 consecutive cycles. Each treatment cycle consisted of 3 weeks of ring/pill treatment followed by a 1-week pill-free period. The women were randomized in a 1:1 ratio to receive the COC containing 30 μg of EE and 3mg of drospirenone (Yasmin; Schering AG, Berlin, Germany)
- control (Type: NO_INTERVENTION): no drugs

Based on this trial design, predict the completion outcome and termination type (if applicable).